Johnson Investment Counsel’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,436
| Closed | -$249K | – | 799 |
|
|
2024
Q3 | $249K | Hold |
6,436
| – | – | ﹤0.01% | 699 |
|
|
2024
Q2 | $207K | Sell |
6,436
-886
| -12% | -$28.5K | ﹤0.01% | 711 |
|
|
2024
Q1 | $284K | Sell |
7,322
-1,015
| -12% | -$39.4K | ﹤0.01% | 622 |
|
|
2023
Q4 | $257K | Buy |
+8,337
| New | +$257K | ﹤0.01% | 620 |
|
|
2023
Q3 | – | Sell |
-9,512
| Closed | -$204K | – | 689 |
|
|
2023
Q2 | $204K | Sell |
9,512
-686
| -7% | -$14.7K | ﹤0.01% | 637 |
|
|
2023
Q1 | $245K | Sell |
10,198
-96,988
| -90% | -$2.33M | ﹤0.01% | 590 |
|
|
2022
Q4 | $2.49M | Sell |
107,186
-19,954
| -16% | -$463K | 0.03% | 206 |
|
|
2022
Q3 | $2.04M | Buy |
127,140
+1,507
| +1% | +$24.1K | 0.03% | 214 |
|
|
2022
Q2 | $2.23M | Sell |
125,633
-1,712
| -1% | -$30.3K | 0.03% | 205 |
|
|
2022
Q1 | $2.59M | Buy |
127,345
+1,520
| +1% | +$31K | 0.03% | 202 |
|
|
2021
Q4 | $2.35M | Buy |
125,825
+1,243
| +1% | +$23.2K | 0.03% | 217 |
|
|
2021
Q3 | $2.46M | Buy |
124,582
+33,813
| +37% | +$667K | 0.03% | 197 |
|
|
2021
Q2 | $2.15M | Sell |
90,769
-172
| -0.2% | -$4.07K | 0.03% | 207 |
|
|
2021
Q1 | $2.16M | Buy |
90,941
+5,581
| +7% | +$132K | 0.03% | 202 |
|
|
2020
Q4 | $1.71M | Buy |
85,360
+1,350
| +2% | +$27K | 0.03% | 216 |
|
|
2020
Q3 | $1.75M | Buy |
84,010
+26,808
| +47% | +$558K | 0.03% | 198 |
|
|
2020
Q2 | $1M | Buy |
+57,202
| New | +$1M | 0.02% | 282 |
|